Press release
Colorectal Cancer Molecular Diagnostics Market to Reach USD 5.07 Billion by 2032 at a 8% CAGR
The global colorectal cancer molecular diagnostics market is projected to grow significantly, reaching a valuation of USD 5.07 billion by 2032 from USD 2.35 billion in 2022, reflecting a CAGR of 8% over the forecast period from 2022 to 2032. This growth is attributed to the rising global incidence of colorectal cancer and advancements in diagnostic laboratories, which are enabling earlier and more precise cancer detection.The increasing prevalence of colorectal cancer is a major factor propelling the growth of the molecular diagnostics market. As the cancer burden continues to rise globally, healthcare systems are placing greater emphasis on early detection and precision medicine. Molecular diagnostic tools are emerging as a key enabler of early-stage detection, allowing for more targeted treatment strategies and improved patient outcomes.
In addition, the development of advanced diagnostic laboratories with cutting-edge molecular testing capabilities is creating a favorable environment for market growth. Laboratories are integrating advanced technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and liquid biopsy techniques to ensure faster, more accurate, and less invasive testing. This, in turn, is fostering greater demand for colorectal cancer molecular diagnostics worldwide.
Looking forward, the global colorectal cancer molecular diagnostics market is poised to experience robust growth, with healthcare systems prioritizing early cancer screening programs and personalized cancer treatment. Increased public and private sector investments in oncology research and development will continue to support the production of more efficient molecular diagnostics technologies.
Request a Sample of this Report Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-8441
Key Takeaways:
The global colorectal cancer molecular diagnostics market is projected to grow from USD 2.35 billion in 2022 to USD 5.07 billion by 2032, at a CAGR of 8%.
Market expansion is driven by the rising prevalence of colorectal cancer and the development of advanced diagnostic laboratories with molecular testing capabilities.
The adoption of technologies such as PCR, next-generation sequencing (NGS), and liquid biopsy is transforming the early detection and treatment landscape for colorectal cancer.
Increased R&D investments and government support for early cancer screening programs are expected to further fuel the growth of the market.
As the need for early cancer diagnosis and personalized treatment grows, the adoption of molecular diagnostic tools for colorectal cancer is set to witness a significant uptick. This shift promises to improve survival rates and reduce the economic burden of cancer care across healthcare systems worldwide.
Key Drivers of Market Growth
Increasing Incidence of Colorectal Cancer: The rising number of colorectal cancer cases globally is a significant factor driving market growth. Approximately 1.4 million new cases are diagnosed each year, highlighting the urgent need for effective diagnostic tools.
Advancements in Diagnostic Laboratories: The development of diagnostic laboratories and improvements in testing technologies enhance the accuracy and speed of colorectal cancer diagnoses, further stimulating market demand.
Growing Awareness and Screening Initiatives: Increased public awareness about colorectal cancer and the importance of early detection has led to more individuals undergoing screening tests, contributing to market growth.
Government Support for Cancer Research: Strong government initiatives aimed at cancer control and research are fostering advancements in molecular diagnostics, which is beneficial for the market.
Technological Innovations: Continuous advancements in molecular diagnostic technologies, including next-generation sequencing and biomarker identification, are improving diagnostic capabilities and expanding their applications.
Regional Insights
North America: Expected to hold the largest market share due to advanced healthcare infrastructure, high prevalence rates of colorectal cancer, and significant investments in research and development.
Asia-Pacific: Anticipated to be the fastest-growing region driven by increasing healthcare expenditures, rising awareness about cancer screening, and improving medical infrastructure.
Market Competition
Some of the key players in the global Colorectal Cancer Molecular Diagnostics market are Dako, Gen Probe (Hologic), Cepheid, Qiagen, Roche Diagnostics, Bayer Healthcare, Abbott Laboratories, Grifols, Guardant Health, Danaher Corporation, Siemens, Beckton Dickinson, Biomérieux Sa, and Sysmex Corporation. Attributed to the presence of such high number of participants, the market is highly competitive.
In May 2022, Guardant Health launched a shield test that simply draws blood to detect the presence of cancer. This test does not require sedation, dietary changes and is less painful. The shield test detects early signs of colorectal cancer signals in the bloodstream.
Key Companies Profiled
Dako
Gen Probe (Hologic)
Cepheid Qiagen
Roche Diagnostics
Bayer Healthcare
Abbott Laboratories
Grifols, Danaher Corporation
Siemens
Beckton Dickinson
Biomérieux Sa
Guardant Health
Sysmex Corporation
Key Segments Profiled in the Colorectal Cancer Molecular Diagnostics Industry Survey
Colorectal Cancer Molecular Diagnostics Market by Product Type:
Colorectal Cancer Molecular Diagnostic Instruments
Colorectal Cancer Molecular Diagnostic Reagents & Kits
Colorectal Cancer Molecular Diagnostic Services
Colorectal Cancer Molecular Diagnostics Market by Technology:
PCR-based Colorectal Cancer Molecular Diagnostics
Sequencing-based Colorectal Cancer Molecular Diagnostics
Mass Spectrometry-based Colorectal Cancer Molecular Diagnostics
Transcription Mediated Amplification-based Colorectal Cancer Molecular Diagnostics
Chips and Microarrays-based Colorectal Cancer Molecular Diagnostics
Isothermal Nucleic Acid Amplification Technology (INAAT) -based Colorectal Cancer Molecular Diagnostics
Colorectal Cancer Molecular Diagnostics Market by End User:
Colorectal Cancer Molecular Diagnostics in Hospitals
Colorectal Cancer Molecular Diagnostics in Ambulatory Surgical Centers
Colorectal Cancer Molecular Diagnostics in Diagnostic Laboratories
Colorectal Cancer Molecular Diagnostics in Homecare Settings
Colorectal Cancer Molecular Diagnostics Market by Region:
North America Colorectal Cancer Molecular Diagnostics Market
Latin America Colorectal Cancer Molecular Diagnostics Market
Europe Colorectal Cancer Molecular Diagnostics Market
Asia Pacific Colorectal Cancer Molecular Diagnostics Market
Middle East & Africa Colorectal Cancer Molecular Diagnostics Market
Explore FMI's Related Ongoing Coverage on Healthcare Market Insights Domain:
Non-invasive Brain Stimulation System Market - https://www.futuremarketinsights.com/reports/non-invasive-brain-stimulation-system-market
Non-Hyaluronic Acid Dermal Filler Market - https://www.futuremarketinsights.com/reports/non-hyaluronic-acid-dermal-filler-market
Non-Hospital-Based Point-Of-Care Diagnostic Products Market - https://www.futuremarketinsights.com/reports/non-hospital-based-point-of-care-diagnostic-products-market
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Colorectal Cancer Molecular Diagnostics Market to Reach USD 5.07 Billion by 2032 at a 8% CAGR here
News-ID: 3792915 • Views: …
More Releases from Future Market Insights

Global Anesthesia Equipment Market to Reach USD 18.2 Billion by 2035
The Anesthesia Equipment Market is witnessing robust growth, with its value estimated at USD 9.3 billion in 2025 and projected to nearly double to USD 18.2 billion by 2035. This growth trajectory represents a compound annual growth rate of 7.0%, driven by increasing surgical volumes, rising prevalence of chronic respiratory and cardiovascular disorders, and ongoing expansion of healthcare infrastructure. The market is undergoing transformative change, as both established manufacturers and…

Intravascular Ultrasound Systems Market to Reach USD 1455.7 Million by 2035
The intravascular ultrasound (IVUS) systems market is on track to record consistent growth over the next decade. Valued at USD 893.7 million in 2025, the market is expected to expand to USD 1455.7 million by 2035, reflecting a compound annual growth rate of 5.0%. With cardiovascular disease remaining one of the leading causes of mortality globally, the demand for advanced intravascular imaging technologies is escalating. IVUS systems, which provide real-time…

Electric Power Sports Market to Reach USD 18.5 Billion by 2035
The global Electric Power Sports Market is on a fast track to transformation, as consumers, manufacturers, and policymakers align on one powerful goal: sustainable, high-performance recreational experiences. Valued at USD 10.3 billion in 2025, the market is projected to expand to USD 18.5 billion by 2035, reflecting a steady compound annual growth rate (CAGR) of 6.0%.
This momentum is set to generate an absolute dollar opportunity of USD 8.2 billion over…

Hair Straightener Market Forecast to Reach USD 12.4 Billion by 2035 as Innovatio …
The global hair straightener market is entering a transformative growth phase, as industry leaders and emerging brands alike innovate to meet rising consumer demand for advanced hair styling solutions. Valued at USD 7.1 billion in 2025, the market is projected to reach USD 12.4 billion by 2035, registering a compound annual growth rate (CAGR) of 5.7% over the forecast period.
Between 2025 and 2030, the market is set to rise steadily…
More Releases for Diagnostic
Rubella Diagnostic Testing Market Report 2024 - Rubella Diagnostic Testing Marke …
"The Business Research Company recently released a comprehensive report on the Global Rubella Diagnostic Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Diagnostic Electrocardiograph Market - Elevating Cardiac Care: Diagnostic Electr …
Newark, New Castle, USA: The "Diagnostic Electrocardiograph Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Diagnostic Electrocardiograph Market: https://www.growthplusreports.com/report/diagnostic-electrocardiograph-market/7804
This latest report researches the industry structure, sales, revenue,…
Diagnostic Imaging Market - Empowering Precision Medicine: Harnessing the Potent …
Newark, New Castle, USA: The "Diagnostic Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2021 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Diagnostic Imaging Market: https://www.growthplusreports.com/report/diagnostic-imaging-market/7688
This latest report researches the industry structure, sales, revenue,…
Rubella Diagnostic Testing Market - Advancing Rubella Control: Innovating Diagno …
Newark, New Castle, USA - new report, titled Rubella Diagnostic Testing Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Rubella Diagnostic Testing market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Rubella Diagnostic Testing market. The report offers an overview of…
Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects.
Tenet Diagnostics got its NABL certification in the fastest time and is…
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends…